A phase 2 trial of pemetrexed and cisplatin followed sequentially by gefitinib versus pemetrexed and cisplatin in Asian 'never smoker' patients with advanced non-small cell lung cancer
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Gefitinib (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 01 Aug 2012 Primary endpoint 'Progression-free-survival-duration' has not been met.
- 01 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jun 2010 Results presented at the 46th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History